| bibliographicCitation |
Altrichter S, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ, Vekovska K, Leflein J, Genova SS, Mandazhieva - Pepelanova M, Marszalska MN, Hofman A, Arnau AMG, Tan R, Noguchi H, Oda Y, Kume A, Seo SJ, Szymanska E, Salvador JFS, Bernstein J, Yamamoto A, Carr W, Mateev G, Treudler R, Klein R, Waibel J, Walczuk BI, Dencheva R, Park YM, Takahagi S, Pulka G, Stanev P, Bauer A, Vasileva I, Kim TG, Bran EL, Metz M, Ruiz JAR, Calatayud AM, Richardson B, Steil K, Lam Y, Cartwright R, Lynn L, Assaad A, . Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial. 2024 Feb 17;(). doi: 10.1093/bjd/ljae067. |